Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Clinical trial NCT01536067 · TERMINATED
Trial details
- NCT number
- NCT01536067
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.